Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice

被引:15
作者
Poole, Lauren G. [1 ,4 ]
Massey, Veronica L. [1 ,4 ]
Siow, Deanna L. [1 ,4 ]
Torres-Gonzales, Edilson [2 ]
Warner, Nikole L. [3 ]
Luyendyk, James P. [5 ]
Ritzenthaler, Jeffrey D. [2 ]
Roman, Jesse [2 ]
Arteel, Gavin E. [1 ,4 ]
机构
[1] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
[2] Univ Louisville, Hlth Sci Ctr, Div Pulm Crit Care & Sleep Disorders Med, Dept Med, Louisville, KY 40292 USA
[3] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[4] Univ Louisville, Alcohol Res Ctr, Louisville, KY 40292 USA
[5] Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Investigat, E Lansing, MI 48824 USA
基金
美国国家卫生研究院;
关键词
alcohol; acute lung injury; inflammation; Serpinel; RESPIRATORY-DISTRESS-SYNDROME; TUMOR-NECROSIS-FACTOR; INDUCED LIVER-INJURY; POTENTIAL ROLE; PAI-1; PLAYS; EXPRESSION; ETHANOL; PLATELETS; ABUSE; INTERLEUKIN-8;
D O I
10.1165/rcmb.2016-0184OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic alcohol exposure is a clinically important risk factor for the development of acute respiratory distress syndrome, the most severe form of acute lung injury (ALI). However, the mechanisms by which alcohol sensitizes the lung to development of this disease are poorly understood. We determined the role of the antifibrinolytic protein plasminogen activator inhibitor-1 (PAI-1) in alcohol enhancement of experimental endotoxin-induced ALI. Wild-type, PAI-1(-/-), and integrin beta(-/-)(3) mice were fed ethanol-containing Lieber-DeCarli liquid or a control diet for 6 weeks, followed by systemic LPS challenge. LPS administration triggered coagulation cascade activation as evidenced by increased plasma thrombin-antithrombin levels and pulmonary fibrin deposition. Ethanol-exposed animals showed enhanced PAI-1 expression and pulmonary fibrin deposition with coincident exaggeration of pulmonary inflammatory edematous injury. PAI-1 deficiency markedly reduced pulmonary fibrin deposition and greatly reduced inflammation and injury without impacting upstream coagulation. Interestingly, pulmonary platelet accumulation was effectively abolished by PAI-1 deficiency in ethanol/LPS-challenged mice. Moreover, mice lacking integrin alpha(IIB)beta(3), the primary platelet receptor for fibrinogen, displayed a dramatic reduction in early inflammatory changes after ethanol/LPS challenge. These results indicate that the mechanism whereby alcohol exaggerates LPS-induced lung injury requires PAI-1-mediated pulmonary fibrin accumulation, and suggest a novel mechanism whereby alcohol contributes to inflammatory ALI by enhancing fibrinogen-platelet engagement.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 50 条
  • [21] Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial Fibrosis
    Gonzalez, Julien
    Klein, Julie
    Chauhan, Sharmila D.
    Neau, Eric
    Calise, Denis
    Nevoit, Caroline
    Chaaya, Rana
    Miravete, Mathieu
    Delage, Christine
    Bascands, Jean-Loup
    Schanstra, Joost P.
    Buffin-Meyer, Benedicte
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (12) : 1511 - 1518
  • [22] The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding
    Marta Helena Kubala
    Yves Albert DeClerck
    Cancer and Metastasis Reviews, 2019, 38 : 483 - 492
  • [23] The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding
    Kubala, Marta Helena
    DeClerck, Yves Albert
    CANCER AND METASTASIS REVIEWS, 2019, 38 (03) : 483 - 492
  • [24] Plasminogen Activator Inhibitor-1 Regulates Myoendothelial Junction Formation
    Heberlein, Katherine R.
    Straub, Adam C.
    Best, Angela K.
    Greyson, Mark A.
    Looft-Wilson, Robin C.
    Sharma, Poonam R.
    Meher, Akshaya
    Leitinger, Norbert
    Isakson, Brant E.
    CIRCULATION RESEARCH, 2010, 106 (06) : 1092 - 1102
  • [25] Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
    Gupta, Kamlesh K.
    Donahue, Deborah L.
    Sandoval-Cooper, Mayra J.
    Castellino, Francis J.
    Ploplis, Victoria A.
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population
    Kodaman, Nuri
    Aldrich, Melinda C.
    Sobota, Rafal
    Asselbergs, Folkert W.
    Brown, Nancy J.
    Moore, Jason H.
    Williams, Scott M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [27] Plasminogen Activator Inhibitor-1 in the Pathophysiology of Late Life Depression
    Metivier, L.
    Vivien, D.
    Goy, R.
    Agin, V.
    Bui, E.
    Benbrika, S.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 39 (11)
  • [28] Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor
    Sen, P.
    Komissarov, A. A.
    Florova, G.
    Idell, S.
    Pendurthi, U. R.
    Rao, L. Vijaya Mohan
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (03) : 531 - 539
  • [29] Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury
    Griemert, Eva-Verena
    Schwarzmaier, Susanne M.
    Hummel, Regina
    Goelz, Christina
    Yang, Dong
    Neuhaus, Winfried
    Burek, Malgorzata
    Foerster, Carola Y.
    Petkovic, Ivan
    Trabold, Raimund
    Plesnila, Nikolaus
    Engelhard, Kristin
    Schaefer, Michael K.
    Thal, Serge C.
    ANNALS OF NEUROLOGY, 2019, 85 (05) : 667 - 680
  • [30] Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases
    Suzuki, Jun-ichi
    Ogawa, Masahito
    Muto, Susumu
    Itai, Akiko
    Hirata, Yasunobu
    Isobe, Mitsuaki
    Nagai, Ryozo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) : 255 - 264